Reduced left ventricular ejection fraction (LVEF) among patients with severe aortic stenosis importantly impacts prognosis in patients treated conservatively, and increases peri-operative risk in patients undergoing surgical aortic valve replacement (SAVR) [1]–[4]. Although mechanical relief of aortic outflow obstruction as accomplished by SAVR has been shown to…
Read more »
indicates a Peer-Reviewed Article
Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation
Transcatheter aortic valve implantation (TAVI) is a treatment option for patients with severe aortic stenosis (AS), who are considered poor candidates for surgical aortic valve replacement (SAVR) primarily due to comorbidities. According to a previous study, 30-day and 6-month survival rates following TAVI and SAVR were comparable, but…
Read more »